Dental Practice Valuation Multiples in California (2026)

Here's the short answer for 2026: a solo general dentistry practice in California is trading somewhere between 4.0x and 6.0x seller's discretionary earnings, a two-doctor group gets 4.5x to 6.5x SDE, and a practice large enough to be a DSO add-on target gets 6.5x to 9.0x adjusted EBITDA, according to the CT Acquisitions Dental and DSO M&A Multiples Report 2026 covering the twelve months ending Q2 2026. If you own one location and you've been told you'll get "a DSO multiple," you won't. The gap between those two numbers is the single most expensive thing most California practice owners misunderstand about their own balance sheet.

The rest of this is how that gap works, what actually moves you across it, and what the math looks like on a real California practice.

Two different yardsticks, and buyers pick the one that favors them

SDE and EBITDA are not the same measurement, and the multiple attached to each is not comparable. SDE adds your owner compensation back into profit, because a solo buyer is purchasing a job plus a business. EBITDA does not add your comp back, because an institutional buyer has to hire a dentist to replace you and that salary is a permanent cost of running the asset.

So when someone quotes you "6x," the first question is 6x of what. Six times SDE on a practice throwing off $470,000 of SDE is a very different check than six times an adjusted EBITDA figure that already subtracted an associate's salary out of that same $470,000. Same practice. Same year. Wildly different price.

This is also why size-tiered tables look more generous than your actual outcome. DealProspectors' 2026 profit-multiple tiers run 5x to 7x for single-location practices, 7x to 9x for small groups, 9x to 11x for mid-tier groups, 10x to 12x for large groups, and 10x to 14x for specialty practices at any size. Read those from the bottom up: the tier ladder is the whole story. Every step up is a step toward a buyer who is pricing a platform, not a chair.

Why California is its own market

California's multiple is shaped by two things that don't show up in a national average: density of licensed supply, and the legal structure a buyer has to build to own you.

The Dental Board of California licenses and regulates roughly 104,000 dental professionals statewide. That is a deep bench of associates and buyers, which cuts both ways. Deep supply means a departing owner can usually find a successor, and it means a DSO can staff a replacement dentist without paying a scarcity premium. It also means your practice is rarely the only one for sale within driving distance of a buyer's target zip code.

The bigger structural factor is the corporate practice of medicine doctrine. California does not let a non-dentist corporation own a dental practice outright. DSO acquisitions here get built as a licensed professional entity paired with a management services organization, with a long-term MSO agreement governing the economics. That structure is routine, but it costs legal money, it takes time, and it introduces regulatory risk the buyer prices into the offer. On a small deal that fixed cost eats a visible share of the purchase price. On a large deal it's rounding. That's one more reason the tier ladder is steeper in California than the headline national ranges suggest.

The consolidation math behind the compression

Solo multiples aren't soft because solo practices got worse. They're soft because the buyer pool changed shape.

ADA Health Policy Institute research shows 72.5% of U.S. dentists were private practice owners in 2023, down from 84.7% in 2005, and 16% of U.S. dentists were affiliated with a DSO in 2024. Read that as a supply-and-demand statement about buyers, not about dentistry. The pool of dentists who want to sign a personal note, take a bank loan, and own a single practice has shrunk by more than twelve percentage points in under two decades. Meanwhile the buyers who are growing are the ones who only want assets that scale.

A DSO paying 6.5x to 9.0x isn't paying that for clinical quality. It's paying for a management layer it doesn't have to build, multiple locations under one integration cost, and earnings that survive the founder walking out. A solo practice fails all three tests, so it gets priced against the shrinking pool of individual buyers instead.

Where the multiple actually comes from

Multiples feel arbitrary until you see the mechanism underneath them. They're not. They're shorthand for a capitalization rate.

The peer-reviewed origin of the method is Manski and Louargand, "Practice Valuation: An Analytical Approach," JADA 1990;120(6):671-676, published in the ADA's own journal. Their capitalization-of-income approach separates the return on tangible assets from the excess earnings the practice generates above that, then capitalizes those excess earnings at a rate reflecting how risky and how durable they are. Today's EBITDA and SDE multiples are that same math with the arithmetic pre-chewed. A 5x multiple is a 20% capitalization rate. A 9x multiple is about 11%.

That reframing is useful because it tells you what you're actually negotiating. You are not arguing about a number on a comp sheet. You are arguing about how risky your earnings look to the person buying them. Every point of multiple you gain is a point of perceived risk you removed.

Operator Math

Take a single-location GP practice in the Sacramento suburbs. Collections of $1,200,000 for the trailing twelve months. Total operating expenses, including the owner's $250,000 in W-2 compensation and about $40,000 of personal expenses running through the business, come to $1,020,000, which leaves net income of $180,000.

Add the owner's compensation and the personal add-backs back in and SDE lands at $470,000.

At the bottom of the solo GP range from the CT Acquisitions 2026 report, 4.0x SDE, that's an enterprise value of $1,880,000.

At the top of that same range, 6.0x, it's $2,820,000.

The spread between a badly prepared version of this practice and a well prepared one is $940,000 on identical collections.

Now run it the way a DSO underwriter runs it. Assume they replace the owner with an associate at 30% of collections, which is $360,000 of new permanent cost.

Subtract that from SDE and adjusted EBITDA is $110,000.

That's an EBITDA margin of roughly 9.2% on collections.

Apply the low end of the DSO add-on range, 6.5x, and the institutional bid is $715,000.

That is less than half the private-buyer price, and it's why the "big DSO multiple" is a trap for a practice this size. The DSO number is real, but it multiplies a much smaller base.

Here's the part worth acting on. Suppose you cut overhead by five points of collections before you sell, which is $60,000 a year in recurring expense.

SDE rises to $530,000.

Adjusted EBITDA rises to $170,000.

At the same 6.5x, the institutional bid becomes $1,105,000.

That's $390,000 of additional enterprise value bought with $60,000 of annual expense reduction.

On the SDE side, the same $60,000 at 5.0x is worth $300,000.

Every recurring dollar you remove from overhead in the eighteen months before a sale gets multiplied five to nine times at closing. Every recurring dollar you add gets multiplied against you the same way.

What actually moves you up the ladder

• Owner dependence. If you personally produce 70% of collections, the buyer is pricing a transition risk, not a business. Associate-produced revenue is worth more per dollar than owner-produced revenue.
• Hygiene as a share of production. Recurring, systematized, low-variance revenue is exactly the kind of earnings stream the capitalization math rewards.
• Payer mix and PPO write-offs. Adjusted production tells the buyer nothing. Collections net of write-offs tells them everything.
• Lease term and location control. A buyer will not pay a platform multiple for earnings that could lose their building in fourteen months.
• Clean books. Personal expenses run through the P&L are normal, and every one of them you can't document is an add-back the buyer deletes.
• Specialty mix. Specialty practices of any size carry 10x to 14x profit multiples in the 2026 DealProspectors tiers. If a meaningful share of your production is specialty and it's performed by someone other than you, say so loudly in the marketing package.

The working capital question underneath all of this

It's the right question to be asking in a valuation article, because the two are connected in a way most owners find out too late.

The improvements that move your multiple almost all require cash before they produce earnings. Hiring an associate to reduce owner dependence costs money for six to twelve months before that associate's production shows up in a trailing-twelve-month number a buyer will credit. Renegotiating a PPO contract or dropping a plan creates a revenue dip before it creates a margin gain. Replacing aging equipment so the buyer doesn't discount for deferred capital spending is a cash outlay this year against a valuation benefit next year.

Owners who run their practice with zero cash buffer can't make any of those moves, so they sell the practice as-is, at the bottom of the range. The buffer isn't defensive. It's what pays for the multiple expansion.

The Takeaway

Figure out which yardstick applies to you before you take a single meeting, because a solo California GP is being valued at 4.0x to 6.0x SDE and no amount of DSO conversation changes that math. Build your trailing twelve months on purpose: cut recurring overhead, document every add-back, extend your lease, and shift production away from your own hands, starting at least eighteen months before you want to close. Model the DSO offer the way the underwriter will, by subtracting a real associate salary from SDE first, so you're never surprised by a bid that's half what you expected. Then decide which buyer type you're actually built for and market to that one, instead of hoping the market decides for you.

If you want to see where your own practice lands on that ladder, the Dental Signal valuation calculator takes your collections, your overhead, and your owner compensation and shows you both numbers side by side: your SDE-based range against the private-buyer multiples above, and your adjusted EBITDA after a replacement-dentist salary against the DSO add-on range. It takes about four minutes and it will tell you fast whether an overhead project or an associate hire is the higher-return move before you sell. Run your own numbers.